DrugPatentWatch Database Preview

Details for Patent: 7,351,723

Which drugs does patent 7,351,723 protect, and when does it expire?

Patent 7,351,723 protects PROTONIX IV and is included in one NDA.

Protection for PROTONIX IV has been extended six months for pediatric studies, as indicated by the *PED designation in the table below.

This patent has fifty-five patent family members in forty countries.

Summary for Patent: 7,351,723

Title:	Freeze-dried pantoprazole preparation and pantoprazole injection
Abstract:	Lyophilized pantoprazole preparations which are obtainable by freeze-drying of an aqueous solution of pantoprazole, ethylenediamine tetraacetic acid and/or a suitable salt thereof, and sodium hydroxide and/or sodium carbonate are disclosed. The preparations have advantageous properties when reconstituted for injection.
Inventor(s):	Linder; Rudolf (Constance, DE), Dietrich; Rango (Constance, DE)
Assignee:	Nycomed GmbH (Constance, DE)
Application Number:	10/855,703
Patent Claim Types: see list of patent claims	Compound;

Drugs Protected by US Patent 7,351,723

Glossary

This preview shows a limited data set. Subscribe for full access, or try a Free Trial
Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	TE	Type	RLD	RS	Patent No.	Patent Expiration	Product	Substance	Delist Req.	Patented / Exclusive Use	Patent Submitted
Wyeth Pharms Inc	PROTONIX IV	pantoprazole sodium	INJECTABLE;IV (INFUSION)	020988-001	Mar 22, 2001	AP	RX	Yes	Yes	➤ Sign Up	➤ Sign Up			Y		➤ Sign Up
Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	TE	Type	RLD	RS	Patent No.	Patent Expiration	Product	Substance	Delist Req.	Patented / Exclusive Use	Patent Submitted

Foreign Priority and PCT Information for Patent: 7,351,723

Foriegn Application Priority Data
Foreign Country	Foreign Patent Number	Foreign Patent Date
	00125569	Nov 22, 2000

Non-Orange Book US Patents Family Members for Patent 7,351,723

For Orange Book-listed patents (shown in the main table above) generic applications must certify that the listed patents are expired, invalid, or will not be infringed by generic entry.

The non-Orange Book patents listed below do not require formal certifications, so they do not automatically impede generic entry. Instead, they represent potential opportunities for branded firms to block generic entry through patent infringment challenges.

This preview shows a limited data set. Subscribe for full access, or try a Free Trial
Patent No.	Title	Estimated Patent Expiration
6,780,881	Freeze-dried pantoprazole preparation and pantoprazole injection	➤ Sign Up
8,754,108	Freeze-dried pantoprazole preparation and pantoprazole injection	➤ Sign Up
Patent No.	Title	Estimated Patent Expiration

International Family Members for US Patent 7,351,723

This preview shows a limited data set. Subscribe for full access, or try a Free Trial
Country	Document Number	Estimated Expiration	Supplementary Protection Certificate	SPC Country	SPC Expiration
Canada	2428870	➤ Sign Up
Canada	2541946	➤ Sign Up
China	1476335	➤ Sign Up
China	1250292	➤ Sign Up
Country	Document Number	Estimated Expiration	Supplementary Protection Certificate	SPC Country	SPC Expiration

Summary for Patent: 7,351,723

Foreign Priority and PCT Information for Patent: 7,351,723

For more information try a trial or see the plans and pricing